- Home
- CON vs AZTA Comparison
CON vs AZTA Comparison
Compare CON & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CON
- AZTA
- Stock Information
- Founded
- CON 1979
- AZTA 1978
- Country
- CON United States
- AZTA United States
- Employees
- CON N/A
- AZTA N/A
- Industry
- CON
- AZTA Industrial Machinery/Components
- Sector
- CON
- AZTA Technology
- Exchange
- CON NYSE
- AZTA Nasdaq
- Market Cap
- CON 2.9B
- AZTA 2.4B
- IPO Year
- CON 2024
- AZTA 1995
- Fundamental
- Price
- CON $23.28
- AZTA $49.02
- Analyst Decision
- CON Strong Buy
- AZTA Buy
- Analyst Count
- CON 7
- AZTA 5
- Target Price
- CON $30.07
- AZTA $67.00
- AVG Volume (30 Days)
- CON 303.3K
- AZTA 679.5K
- Earning Date
- CON 08-01-2024
- AZTA 11-11-2024
- Dividend Yield
- CON N/A
- AZTA N/A
- EPS Growth
- CON N/A
- AZTA N/A
- EPS
- CON 1.74
- AZTA N/A
- Revenue
- CON $1,860,217,000.00
- AZTA $658,617,000.00
- Revenue This Year
- CON N/A
- AZTA $0.52
- Revenue Next Year
- CON N/A
- AZTA $6.51
- P/E Ratio
- CON $13.33
- AZTA N/A
- Revenue Growth
- CON 7.40
- AZTA 4.50
- 52 Week Low
- CON $21.37
- AZTA $44.00
- 52 Week High
- CON $24.81
- AZTA $69.16
- Technical
- Relative Strength Index (RSI)
- CON N/A
- AZTA 48.20
- Support Level
- CON N/A
- AZTA $45.21
- Resistance Level
- CON N/A
- AZTA $48.41
- Average True Range (ATR)
- CON 0.00
- AZTA 1.33
- MACD
- CON 0.00
- AZTA 0.35
- Stochastic Oscillator
- CON 0.00
- AZTA 80.79
About CON CONCENTRA GROUP HOLDINGS PARENT INC
Concentra Group Holdings Parent Inc is a company providing occupational and consumer health services through occupational health centers and onsite clinics. Their services include workers' compensation injury care, employer services, urgent care, clinical testing, wellness programs, and preventative care.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.